CVR number 34714444
Industry 47.9900 Other retail sale not in stores, stalls or markets

DMBIOMASS ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  4.2% 4.2% 4.2% 4.2% 4.2%  
Bankruptcy risk  14.5% 18.1% 17.2% 10.9% 11.3%  
Credit score (0-100)  16 8 9 22 20  
Credit rating  BB B BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  -27.0 -51.6 -23.7 0.0 -11.7  
EBITDA  -27.0 -51.6 -23.7 0.0 -11.7  
EBIT  -27.0 -51.6 -23.7 0.0 -11.7  
Pre-tax profit (PTP)  -36.4 -53.7 9.5 13.1 198.1  
Net earnings  -36.4 -33.8 7.4 10.2 154.5  
Pre-tax profit without non-rec. items  -36.4 -53.7 9.5 24.4 198  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  1,998 1,964 1,971 1,868 1,905  
Interest-bearing liabilities  4.9 0.0 0.0 0.0 9.4  
Balance sheet total (assets)  2,003 1,972 1,982 1,877 1,943  
Net Debt  -1,460 -64.3 -2.1 -79.1 -126  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -27.0 -51.6 -23.7 0.0 -11.7  
Gross profit growth  0.0% -91.2% 54.1% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,003 1,972 1,982 1,877 1,943  
Balance sheet change%  -9.6% -1.5% 0.5% -5.3% 3.5%  
Added value  -27.0 -51.6 -23.7 0.0 -11.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 0.0 -1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 0.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -1.3% -2.3% 0.5% 1.3% 10.4%  
ROI %  -1.3% -2.3% 0.5% 1.3% 10.5%  
ROE %  -1.8% -1.7% 0.4% 0.5% 8.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  99.8% 99.6% 99.5% 99.5% 98.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  5,412.2% 124.6% 8.8% 0.0% 1,076.0%  
Gearing %  0.2% 0.0% 0.0% 0.0% 0.5%  
Net interest  0 0 0 0 0  
Financing costs %  213.5% 326.2% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  385.9 248.4 184.2 213.0 50.9  
Current Ratio  525.3 248.4 184.2 213.0 50.9  
Cash and cash equivalent  1,464.9 64.3 2.1 79.1 135.2  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,998.8 1,963.9 1,971.3 1,868.1 1,904.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0